Cardiology
From the Journals
Fish oil labels make health claims, despite lack of data
“What was surprising, though, was just how broad the types of claims being made were – from heart and brain health to joint health, eye health,...
Conference Coverage
Should clinic BP be routinely measured lying down?
The data revealed that 16% of those without seated hypertension had supine hypertension, while 74% of those with seated hypertension had supine...
Conference Coverage
Sotatercept tied to disease modification in pulmonary arterial hypertension
Data unveiled at the European Respiratory Society International Congress 2023, held in Milan, suggest that sotatercept treatment has the capacity...
Latest News
Lead exposure still a global health burden
Estimates place lead exposure on a par with ambient particulate matter and household air pollution combined, and ahead of unsafe household...
Latest News
Cold weather may challenge blood pressure control
In an observational study, BP control rates decreased by up to 5% during the cold winter months, compared with control rates in the warm summer...
Latest News
Steady VKA therapy beats switch to NOAC in frail AFib patients: FRAIL-AF
The switch resulted in more bleeding without any reduction in thromboembolic complications or all-cause mortality.
Latest News
‘New dawn’ for aldosterone as drug target in hypertension?
The medication lowered systolic blood pressure significantly more than placebo, with the greatest effects seen in adults with obesity.
Latest News
Navigating chronic cough in primary care
“The most common associated comorbidities were heart failure and hypertension, but also conditions related to chronic pain, mood, and anxiety.”
Latest News
Positive topline results for antihypertensive zilebesiran
The small-interfering RNA therapeutic met the primary and secondary endpoints with an “encouraging” safety profile.
Latest News
How do you prescribe exercise in primary prevention?
"We must recommend exercise progressively," says cardiologist Thelma Sánchez Grillo, MD.
Latest News
No benefit of anti-inflammatory strategy in acute myocarditis
Interleukin-1 receptor antagonist anakinra appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.